1 |
CH0113817123 |
Bellevue Biotech DT CHF |
+1,81 % |
+18,28 % |
-0,03 |
2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-1,32 % |
+18,21 % |
-0,20 |
3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-1,54 % |
+18,19 % |
-0,21 |
4 |
LU1269736838 |
Candriam Equities L Biotechnology, R - Capitalisation |
-1,89 % |
+18,61 % |
-0,23 |
5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-1,65 % |
+18,04 % |
-0,22 |
|
61 |
LU0415392322 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B USD - Accumulating |
-3,37 % |
+10,67 % |
-0,54 |
|
73 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-13,77 % |
+17,91 % |
-0,90 |
74 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-5,25 % |
+10,57 % |
-0,72 |
75 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-15,48 % |
+19,23 % |
-0,93 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-34,51 % |
+29,62 % |
-1,25 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-34,59 % |
+29,60 % |
-1,25 |